Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching (Q36203396)

5 March 2018

title

Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching (English)

1 reference

5 March 2018

1 reference

1 reference

1 reference

13

Gert De Hertogh

0 references

Xavier Sagaert

17

object named as

Xavier Sagaert

0 references

Sabine Tejpar

15

object named as

Sabine Tejpar

0 references

Diether Lambrechts

16

object named as

Diether Lambrechts

1 reference

5 March 2018

Linde De Smedt

1

1 reference

5 March 2018

Sofie Palmans

2

1 reference

5 March 2018

Daan Andel

3

1 reference

5 March 2018

Olivier Govaere

4

1 reference

5 March 2018

Bram Boeckx

5

1 reference

5 March 2018

Dominiek Smeets

6

1 reference

5 March 2018

Eva Galle

7

1 reference

5 March 2018

Jasper Wouters

8

1 reference

5 March 2018

David Barras

9

1 reference

5 March 2018

Madeleine Suffiotti

10

1 reference

5 March 2018

Jeroen Dekervel

11

1 reference

5 March 2018

Thomas Tousseyn

12

1 reference

5 March 2018

Hans Prenen

14

1 reference

5 March 2018

language of work or name

English

0 references

publication date

24 November 2016

1 reference

5 March 2018

British Journal of Cancer

published in

1 reference

5 March 2018

volume

116

1 reference

5 March 2018

issue

1

1 reference

5 March 2018

page(s)

58-65

1 reference

5 March 2018

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

copyright license

start time

24 November 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

limma

1 reference

22 June 2022

https://europepmc.org/article/PMC/5220148

inferred from PubMed Central ID database lookup

cites work

The histone variant H2A.X is a regulator of the epithelial-mesenchymal transition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

The consensus molecular subtypes of colorectal cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

i-cisTarget 2015 update: generalized cis-regulatory enrichment analysis in human, mouse and fly.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Molecular and pathogenetic aspects of tumor budding in colorectal cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Stromal contribution to the colorectal cancer transcriptome.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Molecular mechanisms of epithelial-mesenchymal transition

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

i-cisTarget: an integrative genomics method for the prediction of regulatory features and cis-regulatory modules

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Tumour budding: a promising parameter in colorectal cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Fast gapped-read alignment with Bowtie 2

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

GC-content normalization for RNA-Seq data

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Differential expression analysis for sequence count data

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

TGF-beta-induced epithelial to mesenchymal transition

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially c

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Tumor budding as an index to identify high-risk patients with stage II colon cancer.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5220148

Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer

22 September 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2016.382

7 January 2021

Prognostic value of tumor "budding" in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/BJC.2016.382

7 January 2021

Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/BJC.2016.382

7 January 2021

Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/BJC.2016.382

7 January 2021

Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038/BJC.2016.382

7 January 2021

Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038/BJC.2016.382

7 January 2021

Role of APAF-1, E-cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/BJC.2016.382

7 January 2021

Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27884016

12 December 2020

inferred from PubMed ID database lookup

Budding Is Useful to Select High-Risk Patients in Stage II Well-Differentiated or Moderately Differentiated Colon Adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27884016

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.2016.382

1 reference

5 March 2018

PMC publication ID

5220148

1 reference

5 March 2018

PubMed publication ID

27884016

1 reference

5 March 2018